SCHEMBL5313667

SCHEMBL5313667

CCCON=C(COc1cccc(C(=O)OC)c1)c1cc(-c2ccc(Cl)cc2)no1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ NPC1 O15118 4/20 0.48
▸ RAB9A P51151 4/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ TP53 P04637 1/20 0.45
▸ LMNA P02545 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMPD1 P17405 1/20 0.40
▸ NR1H4 Q96RI1 2/20 0.40
▸ THRB P10828 2/20 0.39
▸ NLRP3 Q96P20 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ PTPN1 P18031 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ P2RX3 P56373 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5313664 1.00 MAPT (0.48) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5313697 0.92 MAPT (0.45) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5313691 0.92 MAPT (0.45) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5314639 0.91 RAB9A (0.49) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5314642 0.91 RAB9A (0.49) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5316156 0.83 MAPT (0.41) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5316159 0.83 MAPT (0.41) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5311834 0.83 MAPT (0.47) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5311831 0.83 MAPT (0.47) MAPTSMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL5310815 0.81 PTPN1 (0.40) MAPTSMN1; SMN2NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 — — WO disclosed
Send feedback